240 related articles for article (PubMed ID: 24887266)
1. Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol.
Lalu MM; Moher D; Marshall J; Fergusson D; Mei SH; Macleod M; Griffin G; Turgeon AF; Rudnicki M; Fishman J; Avey MT; Skidmore B; Grimshaw JM; Stewart DJ; Singh K; McIntyre L;
Syst Rev; 2014 May; 3():48. PubMed ID: 24887266
[TBL] [Abstract][Full Text] [Related]
2. Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis.
Carla A; Pereira B; Boukail H; Audard J; Pinol-Domenech N; De Carvalho M; Blondonnet R; Zhai R; Morand D; Lambert C; Sapin V; Ware LB; Calfee CS; Bastarache JA; Laffey JG; Juffermans NP; Bos LD; Artigas A; Rocco PRM; Matthay MA; McAuley DF; Constantin JM; Jabaudon M;
Respir Res; 2020 Apr; 21(1):81. PubMed ID: 32264897
[TBL] [Abstract][Full Text] [Related]
3. Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis.
Dave C; McRae A; Doxtator E; Mei SHJ; Sullivan K; Wolfe D; Champagne J; McIntyre L
Syst Rev; 2020 Aug; 9(1):188. PubMed ID: 32814560
[TBL] [Abstract][Full Text] [Related]
4. Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol.
Barron CC; Lalu MM; Stewart DJ; Fergusson D; Yang H; Moher D; Liu P; Mazer D; Devereaux PJ; McIntyre L;
Syst Rev; 2017 Nov; 6(1):226. PubMed ID: 29116020
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
Suen CM; Zhai A; Lalu MM; Welsh C; Levac BM; Fergusson D; McIntyre L; Stewart DJ
Syst Rev; 2016 May; 5():89. PubMed ID: 27225668
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.
McIntyre LA; Moher D; Fergusson DA; Sullivan KJ; Mei SH; Lalu M; Marshall J; Mcleod M; Griffin G; Grimshaw J; Turgeon A; Avey MT; Rudnicki MA; Jazi M; Fishman J; Stewart DJ;
PLoS One; 2016; 11(1):e0147170. PubMed ID: 26821255
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells for sensorineural hearing loss: protocol for a systematic review of preclinical studies.
Chorath KT; Willis MJ; Morton-Gonzaba N; Humann WJ; Moreira A
Syst Rev; 2019 May; 8(1):126. PubMed ID: 31128597
[TBL] [Abstract][Full Text] [Related]
8. Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol.
Tieu A; Slobodian M; Fergusson DA; Montroy J; Burger D; Stewart DJ; Shorr R; Allan DS; Lalu MM
Syst Rev; 2019 Dec; 8(1):322. PubMed ID: 31831057
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal/stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a systematic review and meta-analysis.
Jansson PM; Lynggaard CD; Carlander AF; Jensen SB; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Grønhøj C; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Menon JML; von Buchwald C
Syst Rev; 2022 Apr; 11(1):72. PubMed ID: 35436971
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol.
Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy in Preclinical Models of Sepsis: A Systematic Review and Meta-analysis.
Hum C; Tahir U; Mei SHJ; Champagne J; Fergusson DA; Lalu M; Stewart DJ; Walley K; Marshall J; Dos Santos CC; Winston BW; Mendelson AA; Dave C; McIntyre L
Stem Cells Transl Med; 2024 Apr; 13(4):346-361. PubMed ID: 38381583
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome-a meta-analysis of preclinical trials.
Wang F; Fang B; Qiang X; Shao J; Zhou L
Respir Res; 2020 Nov; 21(1):307. PubMed ID: 33218340
[TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy for acute respiratory distress syndrome: a promising future?
Horie S; Masterson C; Devaney J; Laffey JG
Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis.
Fengyun W; LiXin Z; Xinhua Q; Bin F
Cell Transplant; 2020; 29():963689720969186. PubMed ID: 33164559
[TBL] [Abstract][Full Text] [Related]
15. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.
Gotts JE; Abbott J; Matthay MA
Am J Physiol Lung Cell Mol Physiol; 2014 Sep; 307(5):L395-406. PubMed ID: 25038188
[TBL] [Abstract][Full Text] [Related]
16. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.
Augustine S; Avey MT; Harrison B; Locke T; Ghannad M; Moher D; Thébaud B
Stem Cells Transl Med; 2017 Dec; 6(12):2079-2093. PubMed ID: 29045045
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.
Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P
Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828
[TBL] [Abstract][Full Text] [Related]
19. Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review.
Dave C; Mei SHJ; McRae A; Hum C; Sullivan KJ; Champagne J; Ramsay T; McIntyre L
Elife; 2022 Jul; 11():. PubMed ID: 35838024
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer.
Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD
Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
